335 related articles for article (PubMed ID: 29165136)
1. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
[TBL] [Abstract][Full Text] [Related]
2. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
3. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
[TBL] [Abstract][Full Text] [Related]
4. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
5. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
[TBL] [Abstract][Full Text] [Related]
6. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
[TBL] [Abstract][Full Text] [Related]
7. RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden.
Ohara M; Yoshimoto T; Okazaki S; Gon Y; Todo K; Sasaki T; Takasugi J; Ohara N; Ihara M; Mochizuki H
J Atheroscler Thromb; 2022 Nov; 29(11):1655-1662. PubMed ID: 34955493
[TBL] [Abstract][Full Text] [Related]
8. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
9. Detailed phenotype of
Zhou H; Jing J; Pu Y; Li W; Meng X; Wang A; Zuo Y; Xu Z; Xu Q; Suo Y; Li H; Wang Y
Stroke Vasc Neurol; 2023 Dec; 8(6):503-510. PubMed ID: 37137523
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis.
Kamimura T; Okazaki S; Morimoto T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Yoshimoto T; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Maruyama H; Koizumi A; Ihara M
Stroke; 2019 Jun; 50(6):1561-1563. PubMed ID: 31060437
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China.
Sun X; Luo M; Li J; Lai R; Lin J; Wang Y; Xu X; Wu S; Sheng W
Mol Genet Genomics; 2020 May; 295(3):635-643. PubMed ID: 32020275
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and intracranial arterial lesions of non-young adult ischemic stroke patients with RNF213 p.R4810K variant.
Ogura S; Ohara T; Tanaka E; Ashida S; Maezono-Kandori K; Hanya M; Mizuta I; Mizuno T
J Neurol Sci; 2023 Sep; 452():120775. PubMed ID: 37657303
[TBL] [Abstract][Full Text] [Related]
13. Comments on "RNF213 p.R4810k Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease".
Liu JC; Zhang Q
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1717-1720. PubMed ID: 29475584
[No Abstract] [Full Text] [Related]
14. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
[TBL] [Abstract][Full Text] [Related]
15. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
[TBL] [Abstract][Full Text] [Related]
16. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.
Liu W; Hitomi T; Kobayashi H; Harada KH; Koizumi A
Neurol Med Chir (Tokyo); 2012; 52(5):299-303. PubMed ID: 22688066
[TBL] [Abstract][Full Text] [Related]
17. Association of Ring Finger Protein 213 Gene P.R4810k Polymorphism with Intracranial Major Artery Stenosis/Occlusion.
Zhang Q; Yu L; Ge P; Ma Y; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1556-1564. PubMed ID: 29482934
[TBL] [Abstract][Full Text] [Related]
18. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
19. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
Morimoto T; Mineharu Y; Ono K; Nakatochi M; Ichihara S; Kabata R; Takagi Y; Cao Y; Zhao L; Kobayashi H; Harada KH; Takenaka K; Funaki T; Yokota M; Matsubara T; Yamamoto K; Izawa H; Kimura T; Miyamoto S; Koizumi A
PLoS One; 2017; 12(4):e0175649. PubMed ID: 28414759
[TBL] [Abstract][Full Text] [Related]
20.
Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
